Leidos price target raised to $140 from $120 at RBC Capital

RBC Capital raised the firm’s price target on Leidos to $140 from $120 and keeps a Sector Perform rating on the shares. The company reported strong Q1 results and the sentiment on the management’s ability to expand margins appears to be gaining momentum as Health segment continues to surprise to the upside, the analyst tells investors in a research note.